Medicine and Dentistry
Sodium Valproate
81%
Neoplasm
62%
Cancer Cell
59%
Histone Deacetylase Inhibitor
50%
Glucose
45%
Colorectal Cancer
40%
Lutetium 177
37%
In Vitro
35%
Therapeutic Procedure
34%
Growth
30%
Insulin
30%
Somatomedin
26%
Colon Cancer
25%
Indium 111
25%
Interferon
25%
Everolimus
22%
Pancreas Cancer
21%
Cell Line
21%
Receptor
18%
Cells
18%
Peptide Receptor
18%
Radiosensitivity
18%
Radionuclide Therapy
18%
Cell Proliferation
17%
Fibroblast
16%
Tumor Microenvironment
16%
Cell Migration
15%
Messenger RNA
12%
Analysis
12%
Somatostatin
12%
Circulation
12%
Entinostat
12%
Radioactive Tracer
12%
Tumor Cell
11%
Growth Factor
11%
Mammalian Target of Rapamycin Inhibitor
11%
Combination Therapy
6%
Chemotherapeutic Agent
6%
Drug
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Immunohistochemistry
6%
Nephrotoxicity
6%
Upregulation
6%
Biodistribution
6%
Mocetinostat
6%
Injection
6%
Panobinostat
6%
Radiopharmaceutical Agent
6%
Blood
6%
Kidney Injury
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gemcitabine
100%
Neoplasm
85%
Pancreas Cancer
69%
Mouse
58%
Cabergoline
50%
Insulin-Like Growth Factor 1
50%
Beta Interferon
50%
Drug
46%
Growth Hormone
46%
Octreotide
34%
Sodium Valproate
28%
Insulin
28%
Primary Culture
26%
Interferon
25%
Everolimus
22%
Tumor Microenvironment
16%
Combination Therapy
14%
Receptor
13%
Cell Proliferation
13%
Prolactin
11%
Mammalian Target of Rapamycin Inhibitor
11%
Prolactinoma
7%
Messenger RNA
7%
Acromegaly
7%
IC50
7%
Histone Deacetylase Inhibitor
7%
Panobinostat
7%
Pharmaceutical Therapy
7%
Clinical Trial
7%
Somatomedin
6%
Enalapril Maleate
6%
Pancreas Islet Cell Tumor
5%